Decrease in Reduced-Form Albumin Among Chronic Kidney Disease Patients: New Insights in Cardiovascular Complications

Therapeutic Apheresis and Dialysis

Volumn 15, Issue 2, 2011, Pages 156-160

  Terawaki, Hiroyuki ^a   Era, Seiichi ^b   Nakayama, Masaaki ^c   Hosoya, Tatsuo ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiovascular disease; Chronic kidney disease; Oxidative stress; Redox state of albumin

Indexed keywords

DIMETHYLAMINE; GLYOXAL; HUMAN MERCAPTOALBUMIN; HUMAN NONMERCAPTOALBUMIN 1; HUMAN NONMERCAPTOALBUMIN 2; HUMAN SERUM ALBUMIN; METHYLGLYOXAL; PARA CRESOL; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OXIDATION REDUCTION REACTION; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION;

ADULT; AGED; AGED, 80 AND OVER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 79953041507     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00889.x     Document Type: Article

References (12)

1. Nakai S, Masakane I, Akiba T etal. Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial 2007;11:411-41.
2. Foley RN, Parfrey PA, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998;32:S112-19.
3. Himmelfarb J, Stenvinkel P, Ikizler TA, Hakim RM. The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. Kidney Int 2002;62:1524-38.
4. Sogami M, Nagoka S, Era S, Honda M, Noguchi K. Resolution of mercapt- and nonmercaptalbumin by high-performance liquid chromatography. Int J Pept Protein Res 1984;24:96-103.
5. Sogami M, Era S, Nagaoka S etal. HPLC-studies on nonmercapt-mercapt conversion of human serum albumin. Int J Pept Protein Res 1985;25:398-402.
6. Terawaki H, Yoshimura K, Hasegawa T etal. Oxidative stress is enhanced in correlation with renal dysfunction: examination with the redox state of albumin. Kidney Int 2004;66:1988-93.
7. Terawaki H, Matsuyama Y, Era S etal. Elevated oxidative stress measured as albumin redox state in continuous ambulatory peritoneal dialysis patients correlates with small uraemic solutes. Nephrol Dial Transplant 2007;22:968.
8. Terawaki H, Nakayama K, Matsuyama Y etal. Dialyzable uremic solutes contribute to enhanced oxidation of serum albumin in regular hemodialysis patients. Blood Purif 2007;25:274-9.
9. Terawaki H, Takada Y, Era S etal. The redox state of albumin and serious cardiovascular incidence in hemodialysis patients. Ther Apher Dial 2010;14:465-71.
10. Matsuyama Y, Hayashi T, Terawaki H etal. Human astrocytes and aortic endothelial cells actively convert the oxidized form of albumin to the reduced form: reduced albumin might participate in redox regulation of nerve and blood vessel systems. J Physiol Sci 2009;59:207-15.
11. Nakayama K, Nakayama M, Iwabuchi M etal. Plasma α-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease. Am J Nephrol 2008;28:1871-8.
12. Terawaki H, Yamada K, Suzuki N etal. The effect of catechin to diabetic nephropathy: preliminary study. Jin To Free Radical 2010;10:91-5. (In Japanese)